Back to Search
Start Over
Development of a Scalable Method for Manufacturing the Central Core of CD73 Inhibitor AB680
- Source :
- Organic Process Research & Development. 25:157-162
- Publication Year :
- 2020
- Publisher :
- American Chemical Society (ACS), 2020.
-
Abstract
- AB680 is a highly potent CD73 small molecule inhibitor discovered and developed by Arcus Biosciences, currently in clinical trials for the treatment of pancreatic cancer. Here, we report the develo...
Details
- ISSN :
- 1520586X and 10836160
- Volume :
- 25
- Database :
- OpenAIRE
- Journal :
- Organic Process Research & Development
- Accession number :
- edsair.doi...........d580f50a6db851b07be5e001c64ef367
- Full Text :
- https://doi.org/10.1021/acs.oprd.0c00469